Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferenc A Scheeren

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Trends in Immunology|July 2, 2020
Genetic Screening for Novel Regulators of Immune Checkpoint MoleculesRamon Arens, Ferenc A Scheeren
The Journal of Investigative Dermatology|January 28, 2021
Inhibition of the Epigenetic Reader BRD4 Reduces SIRPα-Mediated Phagocytosis and Melanoma InvasionFerenc A Scheeren, Remco van Doorn
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2024
Design and Synthesis of DNA Origami Nanostructures to Control TNF Receptor ActivationGöktuğ Aba, Ferenc A Scheeren, Thomas H Sharp
Cancer Discovery|April 4, 2024
Immunogenetic Diversity and Cancer Immunotherapy DisparitiesNoel F C C de Miranda, Ferenc A Scheeren
Immunity|May 21, 2020
The CD47-SIRPα Immune CheckpointMeike E W Logtenberg, Ferenc A Scheeren, Ton N Schumacher
Journal for Immunotherapy of Cancer|July 13, 2022
CD47/SIRPα axis: bridging innate and adaptive immunityAnneloes van Duijn, Sjoerd H Van der Burg, Ferenc A Scheeren
Plos One|April 29, 2011
Antigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5Ferenc A Scheeren, Caroline M M van Geelen, Etsuko Yasuda, et al.
Oncotarget|April 8, 2015
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinomaLovisa Farnebo, Arash Shahangian, Yunqin Lee, et al.
The Journal of Experimental Medicine|August 13, 2008
T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cellsFerenc A Scheeren, Maho Nagasawa, Kees Weijer, et al.
European Journal of Immunology|February 4, 2010
Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiationFerenc A Scheeren, Anja U van Lent, Maho Nagasawa, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Trends in Immunology|July 2, 2020
Genetic Screening for Novel Regulators of Immune Checkpoint MoleculesRamon Arens, Ferenc A Scheeren
The Journal of Investigative Dermatology|January 28, 2021
Inhibition of the Epigenetic Reader BRD4 Reduces SIRPα-Mediated Phagocytosis and Melanoma InvasionFerenc A Scheeren, Remco van Doorn
Methods in Molecular Biology (Clifton, N.J.)|May 6, 2024
Design and Synthesis of DNA Origami Nanostructures to Control TNF Receptor ActivationGöktuğ Aba, Ferenc A Scheeren, Thomas H Sharp
Cancer Discovery|April 4, 2024
Immunogenetic Diversity and Cancer Immunotherapy DisparitiesNoel F C C de Miranda, Ferenc A Scheeren
Immunity|May 21, 2020
The CD47-SIRPα Immune CheckpointMeike E W Logtenberg, Ferenc A Scheeren, Ton N Schumacher
Journal for Immunotherapy of Cancer|July 13, 2022
CD47/SIRPα axis: bridging innate and adaptive immunityAnneloes van Duijn, Sjoerd H Van der Burg, Ferenc A Scheeren
Plos One|April 29, 2011
Antigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5Ferenc A Scheeren, Caroline M M van Geelen, Etsuko Yasuda, et al.
Oncotarget|April 8, 2015
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinomaLovisa Farnebo, Arash Shahangian, Yunqin Lee, et al.
The Journal of Experimental Medicine|August 13, 2008
T cell-independent development and induction of somatic hypermutation in human IgM+ IgD+ CD27+ B cellsFerenc A Scheeren, Maho Nagasawa, Kees Weijer, et al.
European Journal of Immunology|February 4, 2010
Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiationFerenc A Scheeren, Anja U van Lent, Maho Nagasawa, et al.
Pageof 5